The <i>MTNR1B</i> rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus

The <i>MTNR1B</i> rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus

The rs10830963 variant of the <i>Melatonin Receptor 1B</i> (<i>MTNR1B</i>) gene is associated with the development of gestational diabetes mellitus (GDM). We hypothesized that carrying the rs10830963/<i>G</i> risk allele had effect on antenatal insulin therapy (AI...

Full description

Bibliographic Details
Main Authors: Gábor Firneisz, Klara Rosta, Zahra Al-Aissa, Orsolya Hadarits, Jürgen Harreiter, Ákos Nádasdi, Dagmar Bancher-Todesca, László Németh, Péter Igaz, János Rigó, István Sziller, Alexandra Kautzky-Willer, Anikó Somogyi
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:International Journal of Molecular Sciences
Subjects:
gestational diabetes mellitus
GDM
insulin therapy
AIT
lifestyle
medical nutrition therapy
genetics
gene variant
<i>Melatonin Receptor 1B</i> gene
<i>MTNR1B</i>
rs10830963
Online Access:https://www.mdpi.com/1422-0067/19/12/3734

Internet

https://www.mdpi.com/1422-0067/19/12/3734

Similar Items